Influenza is a major cause of worldwide morbidity and mortality through frequent seasonal
epidemics and infrequent pandemics. Morbidity and mortality rates from seasonal influenza …

Several strategies are being pursued to increase the quality and quantity of influenza
vaccines that are used on an annual basis including increasing the immunogenicity of …

In the perspective of reaching at least 75% influenza vaccination coverage in the elderly and
substantial budget constraints, Italian decision makers are facing important challenges in …

Purpose Elderly people are particularly vulnerable to seasonal influenza. Therefore,
vaccination is strongly recommended. However, the vaccine efficacy is lower in the elderly …

Please cite this paper as: Seidman et al.(2012) Quantitative review of antibody response to
inactivated seasonal influenza vaccines. Influenza and Other Respiratory Viruses 6 (1), 52 …

Interest in vaccine adjuvants is intense and growing, because many of the new subunit
vaccine candidates lack sufficient immunogenicity to be clinically useful. In this review, I …

Background Patients receiving chemotherapy are at increased risk for influenza virus
infection. Little is known about the preferred moment of vaccination during chemotherapy …

Despite use of influenza vaccines for more than 65 y, influenza and its complications are a
major cause of morbidity and mortality worldwide. Most deaths during influenza virus …

The most effective means of preventing seasonal influenza is through vaccination. In this
systematic review, we investigated the efficacy, effectiveness and safety of MF59® …

Abstract The addition of 0.5% of a chitosan derivative to inactivated influenza vaccines
injected parenterally resulted in a four or six to tenfold increase in antibody titres after a …